FR2319346B1 - - Google Patents

Info

Publication number
FR2319346B1
FR2319346B1 FR7623355A FR7623355A FR2319346B1 FR 2319346 B1 FR2319346 B1 FR 2319346B1 FR 7623355 A FR7623355 A FR 7623355A FR 7623355 A FR7623355 A FR 7623355A FR 2319346 B1 FR2319346 B1 FR 2319346B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7623355A
Other languages
French (fr)
Other versions
FR2319346A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2319346A1 publication Critical patent/FR2319346A1/fr
Application granted granted Critical
Publication of FR2319346B1 publication Critical patent/FR2319346B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7623355A 1975-07-31 1976-07-30 Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole Granted FR2319346A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3200575 1975-07-31
GB3200475 1975-07-31
GB2718476 1976-06-30

Publications (2)

Publication Number Publication Date
FR2319346A1 FR2319346A1 (fr) 1977-02-25
FR2319346B1 true FR2319346B1 (enExample) 1979-05-25

Family

ID=27258606

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7623355A Granted FR2319346A1 (fr) 1975-07-31 1976-07-30 Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole

Country Status (10)

Country Link
JP (1) JPS5218831A (enExample)
AU (1) AU1643776A (enExample)
DE (1) DE2634409A1 (enExample)
DK (1) DK345676A (enExample)
FR (1) FR2319346A1 (enExample)
IL (1) IL50174A0 (enExample)
LU (1) LU75513A1 (enExample)
NL (1) NL7608503A (enExample)
NZ (1) NZ181635A (enExample)
SE (1) SE7608611L (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
IT1194677B (it) * 1980-08-05 1988-09-22 Italfarmaco Spa Composizione farmaceutica ad attivita' antiflogistica,antipiretica e antalgica
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
US5164406A (en) * 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition

Also Published As

Publication number Publication date
IL50174A0 (en) 1976-09-30
LU75513A1 (enExample) 1977-04-15
SE7608611L (sv) 1977-02-01
DK345676A (da) 1977-02-01
FR2319346A1 (fr) 1977-02-25
AU1643776A (en) 1978-02-02
JPS5218831A (en) 1977-02-12
DE2634409A1 (de) 1977-02-17
NZ181635A (en) 1978-09-25
NL7608503A (nl) 1977-02-02

Similar Documents

Publication Publication Date Title
FR2302538B1 (enExample)
JPS527777U (enExample)
FR2351355B2 (enExample)
JPS5230133U (enExample)
JPS51160593U (enExample)
JPS5212737U (enExample)
JPS51136363U (enExample)
JPS5292703U (enExample)
BG21530A1 (enExample)
CH601696A5 (enExample)
CH576092A5 (enExample)
CH600083A5 (enExample)
CH603493A5 (enExample)
CH599497A5 (enExample)
CH592865A5 (enExample)
CH601833A5 (enExample)
BG22893A1 (enExample)
CH603792A5 (enExample)
CH599019A5 (enExample)
BG21435A1 (enExample)
BG21162A1 (enExample)
BG22513A1 (enExample)
CH599265A5 (enExample)
CH594743A5 (enExample)
CH595962A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse